WKYC3

Fighting For Hope: Pediatric Cancer's Funding Crisis

In our three-part series -- Fighting For Hope: Pediatric Cancer's Funding Crisis -- 3News' Maureen Kyle follows the journey of young patients and their families as they navigate pediatric cancer. This ...

Promising new therapy developed for most common form of bone cancer in children and young adults

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...
The American Journal of Managed Care

New Pediatric Soft Tissue Sarcoma Guidelines Emphasize Risk Stratification, Clinical Trials

The National Comprehensive Cancer Network (NCCN) published new guidelines for pediatric soft tissue sarcoma (STS), growing the NCCN’s library of guidelines to now cover 91 topics in cancer care. 1 ...

Lacrosse clinic raises awareness and funds cancer research typically impacting children

Reporter's Notebook: Ewing sarcoma is a cancer that forms in bone and soft tissue. Around 80 percent of cases impact people under 18 years of age.
Nasdaq

Actuate Therapeutics, Inc. Reports Encouraging Results from Phase 1 Study of Elraglusib in Pediatric Ewing Sarcoma Patients and Plans Phase 2 Trial

Actuate Therapeutics, Inc. has announced the completion of the Phase 1 study evaluating its drug elraglusib in pediatric patients with refractory malignancies, specifically Ewing Sarcoma (EWS). The ...
Nasdaq

Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas

CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
Medscape

Kaposi's Sarcoma in the Pediatric Population: The Critical Need for a Tissue Diagnosis

Kaposi's sarcoma (KS) is a low-grade vascular neoplasm mediated by the human herpesvirus-8. Only 1 clinical subtype, the endemic/African subtype, commonly affects the pediatric population. Although ...
ascopubs.org

Phase II, Randomized, Open-Label Study of Pegfilgrastim-Supported VDC/IE Chemotherapy in Pediatric Sarcoma Patients

Comparison of the Prognostic Value of Assessing Tumor Diameter Versus Tumor Volume at Diagnosis or in Response to Initial Chemotherapy in Rhabdomyosarcoma Whole-Genome Profiling of Pediatric Diffuse ...
ascopubs.org

Mucin 16–Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer Safety and Tolerability of ...
EurekAlert!

AI-driven analysis of digital pathology images may improve pediatric sarcoma subtyping

CHICAGO – An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, according to results presented at the American Association for ...
Seeking Alpha

Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma

Ewing Sarcoma is a Highly Metastatic Form of Sarcoma and the Second Most Prevalent Primary Malignant Tumor in Children and Adolescents Ongoing Enrollment in Phase 1/2 Trial of Elraglusib in ...